Cardiovascular
Latest News
Advertisement
Lipoprotein(a) and Cardiovascular Risk
Learn about more about lipoprotein(a), including how to improve patient outcomes through better screening and management.
Advancements in Population Health Strategies for Cardiovascular Risk Management
Experts discuss how lipoproteins drive atherosclerotic heart disease, review the different guidelines and recommendations on Lp(a) testing, and insights from clinical trials.
Latest Videos
CME Content
Advertisement
More News
The study's lead author said that complications from cardiovascular disease remain an unmet clinical challenge in type 2 diabetes.
While statins are primarily used to lower cholesterol, they are also associated with improved heart structure and function, according to research presented at EuroCMR 2017, which was held by the European Society of Cardiology, May 25-27, in Prague, Czech Republic.
Patients with peripheral artery disease can now have supervised exercise therapy covered by Medicare, according to a recent announcement by CMS.
While regulators long ago saw enough cardiovascular safety data to approve insulin degludec, full trial results will be presented June 12 at the American Diabetes Association Scientific Sessions in San Diego.
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
4
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
5
